Future growth strategy revolves in the field of biologics at our first affiliate office in Cambridge, Massachusetts
Samyang Biopharm USA was established in October 2018 with the goal of conducting R&D activities with an emphasis on the field of immuno-oncology and rare disease drugs. We collaborate with various competitive companies, start-ups, research institutes, hospitals, and universities in the pharmaceutical industry through “Open Innovation” strategy.
31 Jongno 33-gil, jongno-gu, Seoul TEL +82-2-740-7116 FAX +82-2-743-6626
Copylight ⓒ 2013 Samyang Biopharmaceuticals Corporation. All rights Reserved.
